指南与共识骨肌MR

刮除、苯酚化和同种异体骨移植治疗非典型软骨肿瘤/I级软骨肉瘤后的MRI表现:随访建议

MRI appearances of atypical cartilaginous tumour/grade I chondrosarcoma after treatment by curettage, phenolisation and allografting: recommendations for follow-up.
指南 / 共识 · Bone Joint J · 2016-01-01

这项回顾性研究纳入1994至2005年间接受刮除、苯酚化和骨同种异体移植治疗的75例非典型软骨肿瘤/I级软骨肉瘤患者,旨在区分术后正常改变与残留或复发疾病的MRI特征。14例(18.6%)接受二次手术,仅6例(8%)经组织学证实复发,复发时未见肿瘤分级升高。作者据此将术后MRI表现分为四组,各组随访方案和复发风险不同,并给出随访流程图。

要点

  • 术后MRI表现可分为四组,各组随访方案和复发风险不同。
  • 14例(18.6%)接受二次手术,仅6例(8%)经组织学证实复发。
  • 复发时未见肿瘤分级升高。

核心结论

  • 基于本研究,作者将术后MRI表现分为四组,各组随访方案和复发风险不同,并给出针对该特定患者群的安全随访流程图。

研究设计与样本

  • 回顾性研究,纳入1994至2005年间因非典型软骨肿瘤/I级软骨肉瘤接受刮除、苯酚化和骨同种异体移植治疗的75例患者,复习病历、影像和病理资料;首次术后钆增强MRI在术后一年内完成,患者至少接受两次扫描,平均随访72个月(13至169个月)。

关键影像表现/征象

  • 术后MRI表现可分为四组,各组随访方案和复发风险不同。
  • 14例(18.6%)在平均59个月(8至114个月)后接受二次手术。
  • 二次手术中,病灶<10 mm采用射频消融,病灶≥10 mm采用刮除、苯酚化和植骨。

诊断标准与关键数值

  • 二次手术中,病灶<10 mm采用射频消融(RFA),病灶≥10 mm采用刮除、苯酚化和骨移植。
  • 仅6例(占总数的8%)经组织学证实复发。

临床应用与阅片要点

  • 作者根据术后MRI表现将患者分为四组,各组随访方案和复发风险不同,并给出针对该特定患者群的安全随访流程图。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIMS: The purpose of this retrospective study was to differentiate between the MRI features of normal post-operative change and those of residual or recurrent disease after intralesional treatment of an atypical cartilage tumour (ACT)/grade I chondrosarcoma.

PATIENTS AND METHODS: We reviewed the case notes, radiology and histology of 75 patients, who had been treated for an ACT/grade I chondrosarcoma by curettage, phenolisation and bone allografting between 1994 and 2005. The first post-operative Gd-enhanced MRI scan was carried out within one year of surgery. Patients had a minimum of two scans and a mean follow-up of 72 months (13 to 169). Further surgery was undertaken in cases of suspected recurrence.

RESULTS: In 14 patients (18.6%) a second procedure was undertaken after a mean period of 59 months (8 to 114). Radio frequency ablation (RFA) was used in lesions of < 10 mm and curettage, phenolisation and bone grafting for those ≥ 10 mm. Only six of these (8% of total) had a histologically-proven recurrence. No increase in tumour grade was seen at time of recurrence.

CONCLUSION: Based on this study, we have been able to classify the post-operative MRI appearances into four groups. These groups differ in follow-up, and have a different risk of recurrence of the lesion. Follow-up and treatment vary for the patients in each group. We present a flow diagram for the appropriate and safe follow-up for this specific group of patients. Cite this article: Bone Joint J 2016;98-B:1674-81.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Verdegaal SH, van Rijswijk CS, Brouwers HF, et al. MRI appearances of atypical cartilaginous tumour/grade I chondrosarcoma after treatment by curettage, phenolisation and allografting: recommendations for follow-up. Bone Joint J. 2016. PMID: 27909131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。